Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020

Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020

Using a novel recruitment method and paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined seroprevalence in a racially diverse municipality in Louisiana, USA. Infections were highly variable by ZIP code and differed by race/ethnicity. Ov...

Full description

Bibliographic Details
Main Authors: Amy K. Feehan, Daniel Fort, Julia Garcia-Diaz, Eboni G. Price-Haywood, Cruz Velasco, Eric Sapp, Dawn Pevey, Leonardo Seoane
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2020-11-01
Series:Emerging Infectious Diseases
Subjects:
COVID-19
coronavirus disease
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
viruses
respiratory infections
Online Access:https://wwwnc.cdc.gov/eid/article/26/11/20-3029_article
id doaj-0a8e65e9bbd14530bb744f30125b6960
record_format Article
spelling doaj-0a8e65e9bbd14530bb744f30125b69602020-11-25T03:39:16ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592020-11-0126112765276810.3201/eid2611.203029Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020Amy K. FeehanDaniel FortJulia Garcia-DiazEboni G. Price-HaywoodCruz VelascoEric SappDawn PeveyLeonardo Seoane Using a novel recruitment method and paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined seroprevalence in a racially diverse municipality in Louisiana, USA. Infections were highly variable by ZIP code and differed by race/ethnicity. Overall census-weighted seroprevalence was 6.9%, and the calculated infection fatality ratio was 1.63%. https://wwwnc.cdc.gov/eid/article/26/11/20-3029_articleCOVID-19coronavirus diseaseSARS-CoV-2severe acute respiratory syndrome coronavirus 2virusesrespiratory infections
collection DOAJ
language English
format Article
sources DOAJ
author Amy K. Feehan
Daniel Fort
Julia Garcia-Diaz
Eboni G. Price-Haywood
Cruz Velasco
Eric Sapp
Dawn Pevey
Leonardo Seoane
spellingShingle Amy K. Feehan
Daniel Fort
Julia Garcia-Diaz
Eboni G. Price-Haywood
Cruz Velasco
Eric Sapp
Dawn Pevey
Leonardo Seoane
Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
Emerging Infectious Diseases
COVID-19
coronavirus disease
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
viruses
respiratory infections
author_facet Amy K. Feehan
Daniel Fort
Julia Garcia-Diaz
Eboni G. Price-Haywood
Cruz Velasco
Eric Sapp
Dawn Pevey
Leonardo Seoane
author_sort Amy K. Feehan
title Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
title_short Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
title_full Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
title_fullStr Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
title_full_unstemmed Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
title_sort seroprevalence of sars-cov-2 and infection fatality ratio, orleans and jefferson parishes, louisiana, usa, may 2020
publisher Centers for Disease Control and Prevention
series Emerging Infectious Diseases
issn 1080-6040
1080-6059
publishDate 2020-11-01
description Using a novel recruitment method and paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined seroprevalence in a racially diverse municipality in Louisiana, USA. Infections were highly variable by ZIP code and differed by race/ethnicity. Overall census-weighted seroprevalence was 6.9%, and the calculated infection fatality ratio was 1.63%.
topic COVID-19
coronavirus disease
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
viruses
respiratory infections
url https://wwwnc.cdc.gov/eid/article/26/11/20-3029_article
work_keys_str_mv AT amykfeehan seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT danielfort seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT juliagarciadiaz seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT ebonigpricehaywood seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT cruzvelasco seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT ericsapp seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT dawnpevey seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
AT leonardoseoane seroprevalenceofsarscov2andinfectionfatalityratioorleansandjeffersonparisheslouisianausamay2020
_version_ 1724539918860943360

Similar Items